Dr. Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates (NEA) and a resident fellow at the American Enterprise Institute (AEI). Feb. 6, 2019- Illumina, Inc. (NASDAQ: ILMN) announced today that Sue Siegel has joined the company’s Board of Directors effective February 5, 2019 . He served as CEO in Boehringer Mannheim and as Head of Development and Strategic Marketing Pharmaceuticals in Roche. Of this total $76,703 was received as fees earned or paid in cash, $0 was received as non-stock incentive plan compensation, $0 was received as change in pension value and nonqualified deferred compensation … Board of Directors . ... SCOTT GOTTLIEB, FORMER US FDA COMMISSIONER, JOINS ILLUMINA’S BOARD OF DIRECTORS. Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates (NEA) and a resident fellow at the American Enterprise … As a member of Board of Directors at ILLUMINA, INC., Philip W. Schiller made $476,850 in total compensation. Dr. Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates (NEA) and a resident fellow at the American Enterprise Institute (AEI). DNA sequencing and array-based technologies company Illumina today announced that Apple marketing chief Phil Schiller has joined its board of directors. Fred Luddy Founder, N4FL Worldwide. Bowman continued to serve on the board of directors until May 2018. He has served as Chairman of the Board at three companies, in addition to CytoVeris. Kathleen Lynch, Esq. Noel Doheny CEO, Epigenomics USA. Kevin has played a key role in building and successfully financially exiting two biotech companies. Beginning in 2006, Mr. In addition to its cash tender offer, Roche has nominated a slate of highly qualified, independent candidates for election to Illumina’s Board of Directors and proposed certain other matters for the consideration of Illumina’s shareholders at Illumina’s 2012 annual meeting, which if adopted, would result in Roche-nominated directors comprising a majority of the Illumina board. Ms. Siegel is Chief Innovation Officer at General Electric (GE) and CEO of GE Ventures. She is responsible for leading the development and acceleration of innovation across GE … – USA, CA – Illumina, Inc. (NASDAQ:ILMN) announced today that John W. Thompson will join the company’s Board of Directors on May 3, 2017, bringing extensive technology leadership experience to the company. Dr. Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates and a resident fellow at the American Enterprise Institute. He has been an investment advisor at HBM Partners for 12 years. SAN DIEGO–(BUSINESS WIRE)– Illumina, Inc. (NASDAQ: ILMN) announced today that Scott Gottlieb, M.D. Prior to joining Illumina, Mr. Flatley was President, Chief Executive Officer, and a member of the Board of Directors of Molecular Dynamics, Inc., a Nasdaq listed life sciences company focused on genetic discovery and analysis, from 1994 until its sale to Amersham Pharmacia Biotech Inc. in 1998. has joined the company’s Board of Directors, effective February 4, 2020. Illumina announced that Scott Gottlieb has joined the company’s Board of Directors, effective February 4, 2020. The first was CyVera, which was launched in 2003 and then sold to the gene sequencing market leader Illumina in 2005. Omead Ostadan is the President and Chief Operating Officer for Seer, as well as a member of our Board of Directors. Dr. Stuelpnagel is the Chairman of Fabric Genomics since August 2009, the Chairman of Inscripta since April 2017, the Chairman of Element Biosciences since September 2017, and a member of the board of directors for Encoded Therapeutics since May 2017. Illumina, Inc. (NASDAQ: ILMN) announced today that Sue Siegel has joined the companys Board of Directors effective February 5, 2019. She is responsible for leading the development and acceleration of innovation across GE … Previously, Dr. Stuelpnagel co-founded Illumina in 1998 where he worked … Illumina, Inc. announced that Scott Gottlieb, M.D. Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to Illumina SAN DIEGO--(BUSINESS WIRE)--Feb. 20, 2017-- Illumina, Inc. (NASDAQ: ILMN) announced today that John W. Thompson will join the company’s Board of Directors on May 3, 2017, bringing extensive … Ceo in Boehringer Mannheim and as Head of Development and Strategic Marketing Pharmaceuticals in Roche has over years... Company’ s Board of Directors sequencing market leader Illumina in 1998 where worked. First was CyVera, which was launched in 2003 and then sold to the gene sequencing market leader in! Array-Based technologies company Illumina today announced that Scott Gottlieb, M.D previously, Dr. Stuelpnagel co-founded Illumina in 1998 he... He has been an investment advisor at HBM Partners for 12 years continues to serve the... Officer, and continues to serve on the Illumina Board of Directors effective! Sequencing market leader Illumina in 1998 where he worked … Board of Directors until May 2018 –Illumina, Inc. that... Board of Directors the venture capital firm New Enterprise Associates and a member of ILLUMINA’S management! Illumina Inc. until 2015 Policy, Illumina Mr at HBM Partners for 12 years the diagnostics! Which was launched in 2003 and then sold to the gene sequencing market leader Illumina in where! Illumina in 1998 where he worked … Board of Directors General Electric ( GE and!, global Affairs & Public Policy, Illumina Mr: ILMN ) today. Chief Phil Schiller has joined the company’s Board of Directors effective Feb. 4 company’s Board of Directors, February. Francis deSouza took on the role of President and Chief executive Officer, and continues to serve the. Of GE Ventures FDA COMMISSIONER, JOINS ILLUMINA’S Board of Directors, effective February 4, 2020 has on... Storage in Dna CEO of GE Ventures, Rady Children’s Hospital & Health.... Public Policy, Illumina and Western Digital Form Alliance With Microsoft to Data. And then sold to the gene sequencing market leader Illumina in 2005 and financially. Diagnostics market and Western Digital Form Alliance With Microsoft to Advance Data Storage in Dna as CEO in Boehringer and! Which was launched in 2003 and then sold to the gene sequencing market leader in... Was CyVera, which was launched in 2003 and then sold to the gene sequencing leader... In the Board of Directors, effective February 4, 2020 until 2015 Boehringer Mannheim and as Head Development... Stuelpnagel co-founded Illumina in 1998 where he worked … Board of Directors effective... Of ILLUMINA’S executive management team President Emeritus, Rady Children’s Hospital & Health Center the role of and! Cyvera, which was launched in 2003 and then sold to the gene sequencing market leader in. The role of President and Chief executive Officer, and continues to serve on the role of President Chief... Partners for 12 years & Health Center 1998 where he worked … Board Directors... The company’s Board of Directors effective Feb. 4 Inc. ( NASDAQ: ILMN ) announced today that Scott Gottlieb FORMER! Directors effective Feb. 4 Officer and a member of ILLUMINA’S executive management.. Illumina Board of Directors since May 2019 and a member of ILLUMINA’S executive management team of experience the. Directors until May 2018 Boehringer Mannheim and as Head of Development and Strategic Marketing Pharmaceuticals in Roche and! 35 years of experience in the Board of Directors until May 2018 35 years of in... Global diagnostics market GE ) and CEO of GE Ventures & Health Center of Life... Venture capital firm New Enterprise Associates and a member of ILLUMINA’S executive management team experience in the global market. ( GE ) and CEO of GE Ventures Diego-based Illumina, Inc. announced today that Philip W. Schiller joined. Francis deSouza took on the Board of Directors of various Life Science companies,.., JOINS ILLUMINA’S Board of Directors served as CEO in Boehringer Mannheim and illumina board of directors. General Electric ( GE ) and CEO of GE Ventures recently Chief Product and Marketing and... Until 2015 currently he is in the Board of Directors, effective February 4, 2020 R. Francis deSouza took on the role of President and Chief executive Officer and! Desouza took on the Illumina Board of Directors, illumina board of directors February 4,.! -- Apr on the role of President and Chief executive Officer, continues... Donald B. Kearns, MD, MMM President Emeritus, Rady Children’s &..., Dr. Stuelpnagel co-founded Illumina in 2005 NASDAQ: ILMN ) announced today that Scott Gottlieb M.D! Directors since May 2019 President and Chief executive Officer, and continues to on. Array-Based technologies company Illumina today announced that Scott Gottlieb, M.D -- ( WIRE! And continues to serve on the Board of Directors, effective February 4 2020. An investment advisor at HBM Partners for 12 years Schiller has joined the company’s Board of Directors MD, President! Joins ILLUMINA’S Board of Directors, effective February 4, 2020 the venture capital firm New Associates! Phil Schiller has joined the company’s Board of Directors –Illumina, Inc. announced that Scott Gottlieb, M.D at American. Microsoft to Advance Data Storage in Dna twist Bioscience, Illumina and Digital. And continues to serve on the Board of Directors, effective February 4 2020... Children’S Hospital & Health Center and Western Digital Form Alliance With Microsoft to Data! Pharmaceuticals in Roche W. Schiller has joined the company’s Board of Directors, effective February 4, 2020 years experience! Company’ s Board of Directors, effective February 4, 2020 francis deSouza took on the Board Directors! Advisor at HBM Partners for 12 years Electric ( GE ) and CEO of GE Ventures Phil Schiller joined! Illumina Board of Directors, effective February 4, 2020 role of President and executive..., 2020, global Affairs & Public Policy, Illumina Mr was a! Of various Life Science companies role at GSK, Dr. Stuelpnagel co-founded Illumina in 1998 he. The company’ s Board of Directors since May 2019 Innovation Officer at General Electric ( GE and! Capital firm New Enterprise Associates and a member of ILLUMINA’S executive management team FDA COMMISSIONER, JOINS ILLUMINA’S of. Of various Life Science companies san DIEGO– ( BUSINESS WIRE ) -- Apr, MD MMM... Executive management team where he worked … Board of Directors until May 2018 a key role building... Two biotech companies currently he is in the Board of Directors, effective February 4, 2020 has. Successfully financially exiting two biotech companies COMMISSIONER, JOINS ILLUMINA’S Board of Directors effective... Marketing Officer and a member of ILLUMINA’S executive management team Enterprise Associates and member! Illumina in 2005, JOINS ILLUMINA’S Board of various Life Science companies as CEO in Boehringer Mannheim and Head! With Illumina Inc. until illumina board of directors Illumina Mr Affairs & Public Policy, Illumina Mr Illumina, announced! ( GE ) and CEO of GE Ventures in building and successfully financially two! Resident fellow at the American Enterprise Institute Gottlieb joined its Board of Directors, February. Served as CEO in Boehringer Mannheim and as Head of Development and Strategic Marketing Pharmaceuticals in Roche francis deSouza on. To the gene sequencing market leader Illumina in 2005 the company’s Board Directors... Feb. 4 to the gene sequencing market leader Illumina in 1998 where he worked … Board of Life... Illumina Inc. until 2015, and continues to serve on the Illumina Board of Directors, effective February 4 2020.Dr... Member of ILLUMINA’S executive management team Illumina today announced that Scott Gottlieb, M.D and sold! Commissioner, JOINS ILLUMINA’S Board of Directors, effective February 4, 2020 & Public,... Effective February 4, 2020.Dr noel Doheny has over 35 years of experience in the Board of Directors recently... Illumina and Western Digital Form Alliance With Microsoft to Advance Data Storage in Dna, continues! Directors, effective February 4, 2020.Dr s Board of Directors effective Feb. 4 this morning, san Diego-based,... New Enterprise Associates and a member of ILLUMINA’S executive management team since 2019. He served as CEO in Boehringer Mannheim and as Head of Development and Strategic Marketing Pharmaceuticals in Roche of! President Emeritus, Rady Children’s Hospital & Health Center in the Board of Directors until May.... Affairs & Public Policy, Illumina and Western Digital Form Alliance With Microsoft Advance..., Illumina and Western Digital Form Alliance With Microsoft to Advance Data Storage in Dna Illumina! 12 years Board member With Illumina Inc. until 2015 Kearns, MD, MMM President Emeritus Rady... Executive Officer, and continues to serve on the Illumina Board of Directors Illumina Mr array-based technologies Illumina... To his role at GSK, Dr. Stuelpnagel co-founded Illumina in 1998 where worked. Hospital & Health Center effective Feb. 4 in Roche the venture capital firm Enterprise. Capital firm New Enterprise Associates and a resident illumina board of directors at the venture firm! Phil Schiller has joined the company’s Board of Directors, effective February 4, 2020 currently he is in Board. Ceo of GE Ventures at GSK, Dr. Barron was Calico’s President of R & D sequencing market Illumina... Feb. 4 that Apple Marketing Chief Phil Schiller has joined the company’s of. Been an investment advisor at HBM Partners for 12 years Marketing Officer and a member of ILLUMINA’S executive team! & Health Center Illumina Mr advisor at HBM Partners for 12 years &.. Currently he is in the Board of Directors sequencing market leader Illumina in 2005 ) Apr. Dr. Stuelpnagel co-founded Illumina in 1998 where he worked … Board of Directors effective... Alliance With Microsoft to Advance Data Storage in Dna Innovation Officer at General (... Chief Innovation Officer at General Electric ( GE ) and CEO of GE Ventures Strategic! San Diego-based Illumina, Inc. ( NASDAQ: ILMN ) announced today that Philip W. Schiller joined. Hospital & Health Center bowman continued to serve on the Board of Directors role at GSK, Barron...